Reconsidering the ethics of off-label medication use: A response to Braillon and Naudet on baclofen use in alcohol use disorders in India
Indian Journal of Medical Ethics · 2025
DOI: 10.20529/ijme.2025.065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical Ethics, 2025. Verfasst von Dheeraj Kattula. Beteiligte Einrichtung: Professor and Acting Head of Psychiatry-II, Department of Psychiatry, Christian Medical College, Vellore 632 002, INDIA. Hauptthemen laut MEDLINE: Baclofen, Off-Label Use, Alcoholism, GABA-B Receptor Agonists.
Themen: Ethik in der Pflege
Abstract (Originalsprache)
High diffusion of the use of baclofen in patients with alcohol use disorders (AUD) in India has raised concerns from Braillon and Naudet. They say the practice is based on poor evidence and ignores possible harms to patients. This article critiques their arguments and makes a reasoned, ethical, and evidence-informed case for baclofen as a treatment option for AUD, albeit a second-line one, especially because of issues with acceptability and cost of other approved pharmacotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Professor and Acting Head of Psychiatry-II, Department of Psychiatry, Christian Medical College, Vellore 632 002, INDIA.
Zitieren
APA
Kattula, D. (2025). Reconsidering the ethics of off-label medication use: A response to Braillon and Naudet on baclofen use in alcohol use disorders in India. Indian Journal of Medical Ethics. https://doi.org/10.20529/ijme.2025.065
Vancouver
Kattula D. Reconsidering the ethics of off-label medication use: A response to Braillon and Naudet on baclofen use in alcohol use disorders in India. Indian Journal of Medical Ethics. 2025. doi:10.20529/ijme.2025.065
BibTeX
@article{Kattula2025,
author = {Kattula, Dheeraj},
title = {Reconsidering the ethics of off-label medication use: A response to Braillon and Naudet on baclofen use in alcohol use disorders in India},
journal = {Indian Journal of Medical Ethics},
year = {2025},
doi = {10.20529/ijme.2025.065}
}
EUVIMED